Bangalore based Strides Arcolab Ltd has announced that the World Health Organization (WHO) has included in its list of pre-qualified suppliers generic fixed dose combination of anti-HIV drug - Lamivudine /Zidovidine developed by the company.

Prior to this approval, the company has 4 HIV drugs in the WHO pre-qualified list, a Strides release stated.

An additional 3 products have been submitted for pre-qualification, which will complete a comprehensive product offering from the company.

Strides Arcolab Limited has a global presence in more than 50 countries. The company has factories in India, USA, Poland, Italy, Brazil and Mexico. The company supplies pharmaceuticals to a number of geographic locations including Latin America, Europe, South East Asia, Africa and Australia, amongst other markets. The Indian manufacturing facilities for the regulated markets are approved by all major regulatory bodies such as US FDA, MHRA, TGA and MCC.